NCT04025216 2024-01-24
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
Gilead Sciences
Phase 1 Terminated
Gilead Sciences
ImmunoVaccine Technologies, Inc. (IMV Inc.)
ImmunoVaccine Technologies, Inc. (IMV Inc.)
ImmunoVaccine Technologies, Inc. (IMV Inc.)